This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.
Kava Kava
Kava Kava (Piper methysticum) is a traditional South Pacific root herb renowned for its powerful anxiolytic and relaxation-promoting effects. Its active kavalactones modulate GABA receptors to reduce anxiety, promote sociability, and improve sleep - without impairing cognitive function.
Benefits
What is Kava Kava?
Kava Kava (Piper methysticum) is a plant native to the islands of the Western Pacific, where it has been consumed for over 3,000 years in ceremonial, social, and medicinal contexts. The name "kava" comes from the Tongan and Marquesan word for "bitter," reflecting the taste of the traditional beverage prepared from the plant's root.
Kava is unique among anxiolytics in that it produces significant relaxation and anxiety reduction without notably impairing cognitive function. In fact, some research suggests it may even enhance certain aspects of cognition, such as reaction time and visual attention, while reducing anxiety - a combination rarely achieved by pharmaceutical anxiolytics like benzodiazepines.
The active compounds responsible for kava's effects are kavalactones, a class of lactone compounds found primarily in the root and stump of the plant. There are 18 identified kavalactones, with six (kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, and desmethoxyyangonin) accounting for approximately 96% of the pharmacological activity.
- GABA-A receptor modulation: Kavalactones bind to GABA-A receptors and enhance GABAergic inhibition, producing anxiolytic and muscle-relaxant effects without the cognitive impairment seen with benzodiazepines.
- Sodium and calcium channel blockade: Kavain and other kavalactones block voltage-gated sodium and calcium channels, contributing to anxiolytic and analgesic effects.
- MAO-B inhibition: Some kavalactones reversibly inhibit monoamine oxidase B (MAO-B), which may contribute to mood-enhancing effects by preserving dopamine levels.
- Norepinephrine reuptake inhibition: Certain kavalactones inhibit norepinephrine reuptake, which may contribute to kava's mood-elevating properties.
- Endocannabinoid modulation: Yangonin has been shown to bind CB1 cannabinoid receptors, potentially contributing to kava's anxiolytic and euphoric effects.
- Standardised extract: 100–250 mg kavalactones per day, typically split into 2–3 doses
- For anxiety: 120–240 mg kavalactones daily (equivalent to roughly 300–600 mg of extract standardised to 30–70% kavalactones)
- For sleep: 150–200 mg kavalactones taken 1 hour before bed
- Traditional preparation: Kava root powder (2–4 tablespoons) strained in cold water - the traditional method of consumption
- Duration: Clinical studies typically used kava for 4–8 weeks. Avoid continuous daily use beyond 3 months without medical supervision.
Effects are usually felt within 20–30 minutes. Kava should be taken on an empty or light stomach for best results.
- Liver concerns: Rare but serious cases of hepatotoxicity have been reported, leading to restrictions in some countries. Use noble kava cultivars (not tudei/two-day varieties) and root-only preparations to minimise risk.
- Side effects: Dermopathy (dry, scaly skin) with heavy chronic use. Mild GI upset, drowsiness, and headache possible.
- Drug interactions: Do NOT combine with alcohol, benzodiazepines, other sedatives, or hepatotoxic medications. May interact with CYP450 substrates (including antidepressants and antipsychotics).
- Driving: Although kava may not impair cognition at moderate doses, it can cause drowsiness - use caution when driving.
- Pregnancy: Not recommended during pregnancy or breastfeeding.
- Legal status: Restricted or banned in some countries (notably parts of the EU). Check local regulations.
Natural Sources & Forms
- Noble kava cultivars: Traditional, safe varieties preferred for consumption - look for products specifying noble cultivar origin
- Root powder: Ground kava root for traditional water extraction preparation
- Standardised extracts: Capsules or tablets standardised to kavalactone content (typically 30–70%)
- Kava bars: Specialty establishments serving freshly prepared kava beverages, growing in popularity in the US and UK
- Instant kava: Micronised or dehydrated kava preparations that dissolve directly in water
Research Studies
Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study
Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I - Journal of Clinical Psychopharmacology
Kava extract significantly reduced anxiety symptoms by 26% in generalized anxiety disorder patients over 6 weeks.
Kava-kava extract WS 1490 versus placebo in anxiety disorders - a randomized placebo-controlled 25-week outpatient trial
Volz HP, Kieser M - Pharmacopsychiatry
Kava extract produced progressively greater anxiety reductions over 25 weeks without tolerance development.
Frequently Asked Questions
Kava Kava (Piper methysticum) is a traditional South Pacific root herb renowned for its powerful anxiolytic and relaxation-promoting effects. Its active kavalactones modulate GABA receptors to reduce anxiety, promote sociability, and improve sleep - without impairing cognitive function.
The key benefits of Kava Kava include: Anxiety & Calm, Creativity, Focus, Mood, Sleep, Stress Relief.
GABA-A receptor modulation: Kavalactones bind to GABA-A receptors and enhance GABAergic inhibition, producing anxiolytic and muscle-relaxant effects without the cognitive impairment seen with benzodiazepines. Sodium and calcium channel blockade: Kavain and other kavalactones block voltage-gated sodium and calcium channels, contributing to anxiolytic and analgesic effects. MAO-B inhibition: Some kavalactones reversibly inhibit monoamine oxidase B (MAO-B), which may contribute to mood-enhancing effects by preserving dopamine levels. Norepinephrine reuptake inhibition: Certain kavalactones inhibit norepinephrine reuptake, which may contribute to kava's mood-elevating properties. Endocannabinoid modulation: Yangonin has been shown to bind CB1 cannabinoid receptors, potentially contributing to kava's anxiolytic and euphoric effects.
Standardised extract: 100–250 mg kavalactones per day, typically split into 2–3 doses For anxiety: 120–240 mg kavalactones daily (equivalent to roughly 300–600 mg of extract standardised to 30–70% kavalactones) For sleep: 150–200 mg kavalactones taken 1 hour before bed Traditional preparation: Kava root powder (2–4 tablespoons) strained in cold water - the traditional method of consumption Duration: Clinical studies typically used kava for 4–8 weeks. Avoid continuous daily use beyond 3 months without medical supervision. Effects are usually felt within 20–30 minutes. Kava should be taken on an empty or light stomach for best results.
Liver concerns: Rare but serious cases of hepatotoxicity have been reported, leading to restrictions in some countries. Use noble kava cultivars (not tudei/two-day varieties) and root-only preparations to minimise risk. Side effects: Dermopathy (dry, scaly skin) with heavy chronic use. Mild GI upset, drowsiness, and headache possible. Drug interactions: Do NOT combine with alcohol, benzodiazepines, other sedatives, or hepatotoxic medications. May interact with CYP450 substrates (including antidepressants and antipsychotics). Driving: Although kava may not impair cognition at moderate doses, it can cause drowsiness - use caution when driving. Pregnancy: Not recommended during pregnancy or breastfeeding. Legal status: Restricted or banned in some countries (notably parts of the EU). Check local regulations.
Overall Rating
Log in to rate this nootropic.
Comments
Log in to leave a comment.
No comments yet. Be the first to share your experience!